Content area

|
|

No-need-to-see-forløb for binyreincidentalomer

Forfatter(e)

Christian Trolle1, Atul Shukla2, Kirsten Alstrup3, Andreas Kaal4, Stefan Harders5, Klavs Würgler Hansen1 & Per Løgstrup Poulsen6

1) Diagnostisk Center Silkeborg, Medicinsk Afdeling, Hospitalsenhed Midt, 2) Medicinsk Afdeling Viborg, Hospitalsenhed Midt, 3) Medicinsk Afdeling, Regionshospitalet Randers, 4) Medicinsk Afdeling, Regionshospital Horsens, 5) Diagnostisk Center Silkeborg, Røntgen og Skanning, Hospitalsenhed Midt, 6) Diabetes og Hormonsygdomme, Aarhus Universitetshospital

Ugeskr Læger 2020;182:V04200291

Reference: 
UgeskrLæger 2020;182:V04200291
Blad nummer: 
The no-need-to-see process for adrenal incidentalomas

Christian Trolle, Atul Shukla, Kirsten Alstrup, Andreas Kaal, Stefan Harders, Klavs Würgler Hansen & Per Løgstrup Poulsen

Ugeskr Læger 2020;182:V04200291

With wider application and technical improvement of imaging the discovery of adrenal incidentalomas (AI) has been skyrocketing. AI need to be investigated for evidence of hormonal hypersecretion and malignancy, and this causes a considerable use of health resources and potential medicalisation. In the "no-need-to-see" process, the clinical assessment of the citizen will only take place, if the diagnostic tests are abnormal. In this review, we examine the predictive values of imaging and paraclinical testing and argue, that normal test results in people without extra-adrenal cancer exclude disease.

Du skal være logget ind for at læse denne artikel
Log ind

Right side